Literature DB >> 18046568

In vivo modeling of polysumoylation uncovers targeting of Topoisomerase II to the nucleolus via optimal level of SUMO modification.

Yoshimitsu Takahashi1, Alexander Strunnikov.   

Abstract

Conjugation of SUMO to target proteins is an essential eukaryotic regulatory pathway. Multiple potential SUMO substrates were identified among nuclear and chromatin proteins by proteomic approaches. However, the functional roles of SUMO-modified pools of individual proteins remain largely obscure, as only a small fraction of a given target is sumoylated and therefore is experimentally inaccessible. To overcome this technical difficulty in case of Topoisomerase II, we employed constitutive SUMO modification, enabling tracking of modified Top2p, not only biochemically but also cytologically and genetically. Topoisomerase II fused to a critical number of SUMO repeats is concentrated at the specific intranuclear domain, the nucleolus, when more than four SUMO moieties are added, indicating that fused SUMO repeats are biologically active. Further analysis has established that poly-sumoylation of Top2p is required for the stable maintenance of the nucleolar organizer, linking SUMO-mediated targeting to functional maintenance of ribosomal RNA gene cluster.

Mesh:

Substances:

Year:  2007        PMID: 18046568      PMCID: PMC2670096          DOI: 10.1007/s00412-007-0137-1

Source DB:  PubMed          Journal:  Chromosoma        ISSN: 0009-5915            Impact factor:   4.316


  46 in total

1.  Nucleolar delocalization of human topoisomerase I in response to topotecan correlates with sumoylation of the protein.

Authors:  Yin-Yuan Mo; Yanni Yu; Zhiyuan Shen; William T Beck
Journal:  J Biol Chem       Date:  2001-11-14       Impact factor: 5.157

Review 2.  Cellular roles of DNA topoisomerases: a molecular perspective.

Authors:  James C Wang
Journal:  Nat Rev Mol Cell Biol       Date:  2002-06       Impact factor: 94.444

3.  SUMO-1 modification represses Sp3 transcriptional activation and modulates its subnuclear localization.

Authors:  Sarah Ross; Jennifer L Best; Leonard I Zon; Grace Gill
Journal:  Mol Cell       Date:  2002-10       Impact factor: 17.970

4.  Yeast Krr1p physically and functionally interacts with a novel essential Kri1p, and both proteins are required for 40S ribosome biogenesis in the nucleolus.

Authors:  T Sasaki; A Toh-E; Y Kikuchi
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

5.  A distinct subnuclear localization of mammalian DNA topoisomerase IIbeta in yeast.

Authors:  A Sakaguchi; T Akashi; A Kikuchi
Journal:  Biochem Biophys Res Commun       Date:  2001-05-18       Impact factor: 3.575

6.  Saccharomyces cerevisiae SMT4 encodes an evolutionarily conserved protease with a role in chromosome condensation regulation.

Authors:  A V Strunnikov; L Aravind; E V Koonin
Journal:  Genetics       Date:  2001-05       Impact factor: 4.562

7.  Conserved function of RNF4 family proteins in eukaryotes: targeting a ubiquitin ligase to SUMOylated proteins.

Authors:  Huaiyu Sun; Joel D Leverson; Tony Hunter
Journal:  EMBO J       Date:  2007-08-30       Impact factor: 11.598

8.  Ubiquitin-dependent proteolytic control of SUMO conjugates.

Authors:  Kristina Uzunova; Kerstin Göttsche; Maria Miteva; Stefan R Weisshaar; Christoph Glanemann; Marion Schnellhardt; Michaela Niessen; Hartmut Scheel; Kay Hofmann; Erica S Johnson; Gerrit J K Praefcke; R Jürgen Dohmen
Journal:  J Biol Chem       Date:  2007-08-29       Impact factor: 5.157

9.  The yeast ULP2 (SMT4) gene encodes a novel protease specific for the ubiquitin-like Smt3 protein.

Authors:  S J Li; M Hochstrasser
Journal:  Mol Cell Biol       Date:  2000-04       Impact factor: 4.272

10.  The SUMO-1 isopeptidase Smt4 is linked to centromeric cohesion through SUMO-1 modification of DNA topoisomerase II.

Authors:  Jeff Bachant; Annette Alcasabas; Yuval Blat; Nancy Kleckner; Stephen J Elledge
Journal:  Mol Cell       Date:  2002-06       Impact factor: 17.970

View more
  17 in total

Review 1.  DNA topoisomerase II and its growing repertoire of biological functions.

Authors:  John L Nitiss
Journal:  Nat Rev Cancer       Date:  2009-04-20       Impact factor: 60.716

2.  DNA topoisomerase II is a determinant of the tensile properties of yeast centromeric chromatin and the tension checkpoint.

Authors:  Tariq H Warsi; Michelle S Navarro; Jeff Bachant
Journal:  Mol Biol Cell       Date:  2008-08-13       Impact factor: 4.138

3.  Purification and identification of endogenous polySUMO conjugates.

Authors:  Roland Bruderer; Michael H Tatham; Anna Plechanovova; Ivan Matic; Amit K Garg; Ronald T Hay
Journal:  EMBO Rep       Date:  2011-01-21       Impact factor: 8.807

Review 4.  SUMO-mediated regulation of DNA damage repair and responses.

Authors:  Prabha Sarangi; Xiaolan Zhao
Journal:  Trends Biochem Sci       Date:  2015-03-13       Impact factor: 13.807

Review 5.  SUMO modification of DNA topoisomerase II: trying to get a CENse of it all.

Authors:  Ming-Ta Lee; Jeff Bachant
Journal:  DNA Repair (Amst)       Date:  2009-02-20

6.  The dynamics of DNA topoisomerase IIalpha in living cells.

Authors:  John R Daum; Yin Yuan Mo; Gary J Gorbsky
Journal:  Methods Mol Biol       Date:  2009

7.  SUMOylation-disrupting WAS mutation converts WASp from a transcriptional activator to a repressor of NF-κB response genes in T cells.

Authors:  Koustav Sarkar; Sanjoy Sadhukhan; Seong-Su Han; Yatin M Vyas
Journal:  Blood       Date:  2015-08-10       Impact factor: 22.113

Review 8.  The implication of Sir2 in replicative aging and senescence in Saccharomyces cerevisiae.

Authors:  Cheol Woong Ha; Won-Ki Huh
Journal:  Aging (Albany NY)       Date:  2011-03       Impact factor: 5.682

Review 9.  Topoisomerase II: a fitted mechanism for the chromatin landscape.

Authors:  Joaquim Roca
Journal:  Nucleic Acids Res       Date:  2008-12-05       Impact factor: 16.971

10.  Cooperation of sumoylated chromosomal proteins in rDNA maintenance.

Authors:  Yoshimitsu Takahashi; Stanimir Dulev; Xianpeng Liu; Natalie Jasmin Hiller; Xiaolan Zhao; Alexander Strunnikov
Journal:  PLoS Genet       Date:  2008-10-10       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.